Key result
Synthetic torpor reduces myocardial infarct size by ~40% in rat ischemia-reperfusion models.
Why the study?
Species that naturally enter torpor are tolerant of ischaemia-reperfusion injury, sparking interest in clinical applications such as protection from myocardial infarction. However, it remained unknown whether inducing a torpor-like state is protective in animals that do not naturally enter torpor.
Does chemogenetically induced synthetic torpor reduce myocardial infarct size following ex vivo ischaemia-reperfusion injury in rats?
Does chemogenetically induced synthetic torpor reduce myocardial infarct size following ex vivo ischaemia-reperfusion injury in rats?
This preclinical study demonstrates for the first time that inducing a synthetic torpor state in a non-hibernating species (the rat) confers significant cardioprotection against ischaemia-reperfusion injury independent of hypothermia.
Answers are grounded in this paper and cite their sources.
Synthetic torpor confers ex vivo cardioprotection in rats; leaves open translation to in vivo or clinical settings.
During times of environmental stress, many animals enter torpor: a reversible protective physiological state typically characterised by reductions in core temperature, heart rate, and oxygen consumption. Species that naturally enter this hypothermic and hypometabolic state are tolerant of ischaemia-reperfusion injury. Consequently, there is a growing interest in utilising aspects of torpor for clinical applications such as protection from stroke or myocardial infarction. It is currently unknown, however, whether a torpor-like state is protective in animals that do not naturally enter torpor. Using viral vector-mediated chemogenetic activation of the medial preoptic area of the hypothalamus, we induced synthetic torpor in the rat, a species that does not naturally enter torpor. We demonstrate this state is cardioprotective in an ex vivo ischaemia-reperfusion injury model with an ~40% reduction in infarct size. Synthetic torpor-induced cardioprotection of the normothermic, isolated heart is not dependent on prior hypothermia in vivo. Phosphoproteomic analysis of cardiac tissue indicates that the protective effects of synthetic torpor may be mediated by parallel activation of cell survival and stress tolerance pathways and inhibition of cell death pathways. These findings provide important insights into the mechanisms of organ protective effects of synthetic torpor states with implications for future clinical translation in humans.
No takes yet. Share an insight, caveat, or question.
Elley et al. (2026) studied Ex vivo cardiac ischaemia-reperfusion injury (n=39). Chemogenetic synthetic torpor via AAV-CaMKIIa-hM3D(Gq)-mCherry injection into the medial preoptic area activated by clozapine-N-oxide (CNO) vs. Control vector AAV-CaMKIIa-EGFP (200 nl bilateral, 2.8x10^13 vg/ml) into the medial preoptic area followed by 2 mg/kg intraperitoneal CNO was evaluated on Percentage of infarcted myocardium measured by 2,3,5-triphenyltetrazolium chloride (TTC) staining after 30 minutes of global ischaemia and 60 minutes of reperfusion (39.5% relative reduction in infarct size, p=0.039). Chemogenetically induced synthetic torpor in rats reduced myocardial infarct size by 39.5% compared to controls in an ex vivo ischaemia-reperfusion model.
Synapse has enriched 10 related papers. Consider them for comparative context: